Med Holdings Group Negotiates with Leading Urologist Dr. Harvey Samowitz as It Expands into New Markets

Med Holdings Group Inc. is in advanced talks to bring on board renowned urologist Dr. Harvey Samowitz, while accelerating expansion into Florida markets and launching a national digital platform, signaling a strategic push to scale its healthcare operations.

NY Metrowire Staff
Business
Med Holdings Group Negotiates with Leading Urologist Dr. Harvey Samowitz as It Expands into New Markets

Med Holdings Group Inc. (OTC: YUKA) has entered advanced negotiations with Dr. Harvey Samowitz, a nationally recognized urology and sexual wellness specialist, as part of its strategy to strengthen clinical leadership and accelerate growth. Dr. Samowitz brings over 30 years of experience in urology, sexual medicine, and pelvic health, and is board certified by the American Board of Urology with a subspecialty in Female Pelvic Medicine and Reconstructive Surgery. His affiliations include the American Urological Association and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction.

The company is also actively expanding into high-growth markets in Florida, with negotiations underway for new locations in Jupiter and Doral. These markets align with Med Holdings' demographic strategy targeting high-income areas. Management expects these additions to materially strengthen recurring revenue and regional brand dominance.

In parallel, Med Holdings is accelerating its audit process and advancing its FINRA name and ticker symbol change to enhance transparency and market visibility. The company has officially launched its enhanced national platform, TotallBody.com, which provides immediate national brand exposure and access to a large, underserved U.S. market. This digital infrastructure is seen as foundational for scaling a nationally recognized healthcare platform.

Over the past twelve months, YUKA has appreciated more than 500%, with its market capitalization exceeding $3 million. Management believes this growth reflects increasing investor awareness of the company's strategic direction. With committed expansion capital, a clear acquisition strategy, and accelerating compliance milestones, Med Holdings Group is positioning itself for continued growth in 2026 and beyond.

CEO Jessica Miller emphasized that aligning with elite medical leadership and scaling into high-demand markets are key to building a nationally recognized brand. The company will provide updates as negotiations and expansion initiatives progress.

Blockchain Registration

QR Code for Blockchain Registration